181 related articles for article (PubMed ID: 19250272)
1. The relationship between thyroid function, serum monokine induced by interferon gamma and soluble interleukin-2 receptor in thyroid autoimmune diseases.
Jiskra J; Antosová M; Límanová Z; Telicka Z; Lacinová Z
Clin Exp Immunol; 2009 May; 156(2):211-6. PubMed ID: 19250272
[TBL] [Abstract][Full Text] [Related]
2. Thyroid function and thyroid autoimmunity independently modulate serum concentration of soluble interleukin 2 (IL-2) receptor (sIL-2R) in thyroid diseases.
Mariotti S; Caturegli P; Barbesino G; Marinò M; Del Prete GF; Chiovato L; Tonacchera M; De Carli M; Pinchera A
Clin Endocrinol (Oxf); 1992 Nov; 37(5):415-22. PubMed ID: 1486691
[TBL] [Abstract][Full Text] [Related]
3. High potential to tumor necrosis factor alpha (TNF-alpha) production of thyroid infiltrating T lymphocytes in Hashimoto's thyroiditis: a peculiar feature of destructive thyroid autoimmunity.
Del Prete GF; Tiri A; De Carli M; Mariotti S; Pinchera A; Chretien I; Romagnani S; Ricci M
Autoimmunity; 1989; 4(4):267-76. PubMed ID: 2518830
[TBL] [Abstract][Full Text] [Related]
4. In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis.
Matsubayashi S; Akasu F; Kasuga Y; Snow K; Keystone E; Volpé R
Clin Exp Immunol; 1990 Oct; 82(1):63-8. PubMed ID: 1976464
[TBL] [Abstract][Full Text] [Related]
5. Cytokines serum levels as the markers of thyroid activation in Graves' disease.
Komorowski J; Jankiewicz J; Robak T; Błasińska-Morawiec M; Stepień H
Immunol Lett; 1998 Feb; 60(2-3):143-8. PubMed ID: 9557956
[TBL] [Abstract][Full Text] [Related]
6. Decreased serum level of IL-7 in patients with active Graves' disease.
Motylewska E; Nieć M; Siejka A; Komorowski J; Ławnicka H; Świętosławski J; Stępień H
Cytokine; 2015 Oct; 75(2):373-9. PubMed ID: 26113403
[TBL] [Abstract][Full Text] [Related]
7. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2).
Phenekos C; Vryonidou A; Gritzapis AD; Baxevanis CN; Goula M; Papamichail M
Neuroimmunomodulation; 2004; 11(4):209-13. PubMed ID: 15249726
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous measurement of twenty-nine circulating cytokines and growth factors in female patients with overt autoimmune thyroid diseases.
Cheng CW; Wu CZ; Tang KT; Fang WF; Lin JD
Autoimmunity; 2020 Aug; 53(5):261-269. PubMed ID: 32338082
[TBL] [Abstract][Full Text] [Related]
9. 25-Hydroxyvitamin D serum level in Hashimoto's thyroiditis, but not Graves' disease is relatively deficient.
Ke W; Sun T; Zhang Y; He L; Wu Q; Liu J; Zha B
Endocr J; 2017 Jun; 64(6):581-587. PubMed ID: 28413173
[TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking.
Salvi M; Pedrazzoni M; Girasole G; Giuliani N; Minelli R; Wall JR; Roti E
Eur J Endocrinol; 2000 Aug; 143(2):197-202. PubMed ID: 10913938
[TBL] [Abstract][Full Text] [Related]
11. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
[TBL] [Abstract][Full Text] [Related]
12. Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls.
Kristensen B
Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836805
[TBL] [Abstract][Full Text] [Related]
13. Methimazole has no dose-related effect on the serum concentrations of soluble class I major histocompatibility complex antigens, soluble interleukin-2 receptor, and beta 2-microglobulin in patients with Graves' disease.
Escobar-Morreale HF; Serrano-Gotarredona J; Villar LM; García-Robles R; González-Porqué P; Sancho JM; Varela C
Thyroid; 1996 Feb; 6(1):29-36. PubMed ID: 8777381
[TBL] [Abstract][Full Text] [Related]
14. IL-14 and IL-16 are expressed in the thyroid of patients with either Graves' disease or Hashimoto's thyroiditis.
Kemp EH; Ajjan RA; Metcalfe RA; Watson PF; Weetman AP
Clin Endocrinol (Oxf); 2015 Nov; 83(5):726-32. PubMed ID: 25940130
[TBL] [Abstract][Full Text] [Related]
15. Increased IL-21/IL-21R expression and its proinflammatory effects in autoimmune thyroid disease.
Guan LJ; Wang X; Meng S; Shi LF; Jiang WJ; Xiao L; Shi XH; Xu J; Zhang JA
Cytokine; 2015 Apr; 72(2):160-5. PubMed ID: 25647271
[TBL] [Abstract][Full Text] [Related]
16. Detection and localization of chemokine gene expression in autoimmune thyroid disease.
Kemp EH; Metcalfe RA; Smith KA; Woodroofe MN; Watson PF; Weetman AP
Clin Endocrinol (Oxf); 2003 Aug; 59(2):207-13. PubMed ID: 12864798
[TBL] [Abstract][Full Text] [Related]
17. Thyrotropin-receptor and thyroid peroxidase-specific T cell clones and their cytokine profile in autoimmune thyroid disease.
Fisfalen ME; Palmer EM; Van Seventer GA; Soltani K; Sawai Y; Kaplan E; Hidaka Y; Ober C; DeGroot LJ
J Clin Endocrinol Metab; 1997 Nov; 82(11):3655-63. PubMed ID: 9360522
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous assay for three types of thyrotropin receptor antibody activities using FRTL-5 cells in patients with autoimmune thyroid diseases.
Zhu Y; Portmann L; Dénéréaz N; Lemarchand-Béraud T
Eur J Endocrinol; 1994 Oct; 131(4):359-68. PubMed ID: 7921224
[TBL] [Abstract][Full Text] [Related]
19. Increased differentiation of Th22 cells in Hashimoto's thyroiditis.
Bai X; Sun J; Wang W; Shan Z; Zheng H; Li Y; Zhao Y; Gong M; Teng W
Endocr J; 2014; 61(12):1181-90. PubMed ID: 25242258
[TBL] [Abstract][Full Text] [Related]
20. Immunoexpression of the CD30 ligand/CD30 and IL-6/IL-6R signals in thyroid autoimmune diseases.
Ruggeri RM; Barresi G; Sciacchitano S; Trimarchi F; Benvenga S; Trovato M
Histol Histopathol; 2006 Mar; 21(3):249-56. PubMed ID: 16372246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
